The recent shift in Health Economics and Outcomes Research functions across major pharmaceutical companies highlights a lack of understanding of its value. Health Economics and Outcomes Research (HEOR ...
The HEOR capability within the pharmaceutical industry is at a tipping point.On one hand are two well-attended recent conferences (ISPOR-US and EU, 2024) with a total of over 10,500 attendees joining ...
As local payers come under more pressure to constrain costs, the value of Health Economics and Outcomes Research (HEOR) is increasing. The involvement of market access teams at every stage of ...
Open Health has joined forces with health economics and outcomes research (HEOR) company Pharmerit International in a move that strengthens its existing market access capabilities. The integration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback